Nanomaterials (Jan 2023)

Nano-Delivery System of Ethanolic Extract of Propolis Targeting <i>Mycobacterium tuberculosis</i> via Aptamer-Modified-Niosomes

  • Sirikwan Sangboonruang,
  • Natthawat Semakul,
  • Sureeporn Suriyaprom,
  • Kuntida Kitidee,
  • Jiaranai Khantipongse,
  • Sorasak Intorasoot,
  • Chayada Sitthidet Tharinjaroen,
  • Usanee Wattananandkul,
  • Bordin Butr-Indr,
  • Ponrut Phunpae,
  • Khajornsak Tragoolpua

DOI
https://doi.org/10.3390/nano13020269
Journal volume & issue
Vol. 13, no. 2
p. 269

Abstract

Read online

Tuberculosis (TB) therapy requires long-course multidrug regimens leading to the emergence of drug-resistant TB and increased public health burden worldwide. As the treatment strategy is more challenging, seeking a potent non-antibiotic agent has been raised. Propolis serve as a natural source of bioactive molecules. It has been evidenced to eliminate various microbial pathogens including Mycobacterium tuberculosis (Mtb). In this study, we fabricated the niosome-based drug delivery platform for ethanolic extract of propolis (EEP) using thin film hydration method with Ag85A aptamer surface modification (Apt-PEGNio/EEP) to target Mtb. Physicochemical characterization of PEGNio/EEP indicated approximately −20 mV of zeta potential, 180 nm of spherical nanoparticles, 80% of entrapment efficiency, and the sustained release profile. The Apt-PEGNio/EEP and PEGNio/EEP showed no difference in these characteristics. The chemical composition in the nanostructure was confirmed by Fourier transform infrared spectrometry. Apt-PEGNio/EEP showed specific binding to Mycobacterium expressing Ag85 membrane-bound protein by confocal laser scanning microscope. It strongly inhibited Mtb in vitro and exhibited non-toxicity on alveolar macrophages. These findings indicate that the Apt-PEGNio/EEP acts as an antimycobacterial nanoparticle and might be a promising innovative targeted treatment. Further application of this smart nano-delivery system will lead to effective TB management.

Keywords